Renal denervation as an option for the management of hypertension

Journal of Biomedical Research

Volumn 28, Issue 1, 2014, Pages 18-24

  Santiapillai, Georgina Radhini ^a   Ferro, Albert ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Blood pressure; Hypertension; Renal denervation

Indexed keywords

EID: 84913536593     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.27.20130036     Document Type: Article

References (23)

1. World Health Organisation. The top 10 causes of death. 2011; Available at: http://www.who.int/mediacentre/ factsheets/fs310/en/index.html. (accessed 12/05, 2012).
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23.
3. Poulter N. Global risk of cardiovascular disease. Heart 2003; 89(S2): ii2-ii5.
4. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hyperten-sion in non-hypertensive participants in the Framing-ham Heart Study: a cohort study. Lancet 2001; 358: 1682-86.
5. Mancia G. Blood pressure reduction and cardiovascular outcomes: past, present, and future. Am J Cardiol 2007; 100 (S): 3J-9J.
6. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evalu-ation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Re-search. Circulation 2008; 117: e510-26.
7. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol 2008; 52: 1749-57.
8. Schlaich MP, Krum H, Sobotka PA, Esler MD. Renal denervation and hypertension. Am J Hypertens 2011; 24: 635-42.
9. Atherton DS, Deep NL, Mendelsohn FO. Micro-anatomy of the renal sympathetic nervous system: a human post-mortem histologic study. Clin Anat 2012; 25: 628-33.
10. DiBona GF. Neural control of the kidney: past, present, and future. Hypertension 2003; 41: 621-4.
11. Morrissey DM, Brookes VS, Cooke WT. Sympathec-tomy in the treatment of hypertension; review of 122 cases. Lancet 1953; 1: 403-8.
12. National Institute for Health and Clinical Excellence. Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension. 2012; Available at: http://guidance.nice.org.uk/ipg418. (accessed 11/19, 2012).
13. Grimson KS. Total Thoracic and partial to total lumbar sympathectomy and celiac ganglionectomy in the treat-ment of hypertension. Ann Surg 1941; 114: 753-75.
14. Holmes D, Fish JM, Byrd IA, Dando JD, Fowler SJ, Cao H, et al. Contact sensing provides a highly accurate means to titrate radiofrequency ablation lesion depth. J Cardiovasc Electrophysiol 2011; 22: 684-90.
15. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995; 25: 893-7.
16. Ye S, Zhong H, Yanamadala V, Campese VM. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens 2002; 15: 717-24.
17. Rippy MK, Zarins D, Barman NC, Wu A, Duncan KL, Zarins CK. Catheter-based renal sympathetic denerva-tion: chronic preclinical evidence for renal artery safety. Clin Res Cardiol 2011; 100: 1095-1101.
18. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sad-owski J, Bartus K, et al. Catheter-based renal sympa-thetic denervation for resistant hypertension: a multi-centre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275-81.
19. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: du-rability of blood pressure reduction out to 24 months. Hypertension 2011; 57: 911-7.
20. Kaye DM, Esler M, Kingwell B, McPherson G, Esmore D, Jennings G. Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after car-diac transplantation in humans. Circulation 1993; 88: 1110-8.
21. Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, et al. Re-nal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376: 1903-9.
22. Grassi G, Mancia G. New therapeutic approaches for re-sistant hypertension. J Nephrol 2012; 25: 276-81.
23. Doumas M, Douma S. Renal sympathetic denervation: the jury is still out. Lancet 2010; 376: 1878-80.